Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1970 Jul;39(3):556-63.
doi: 10.1111/j.1476-5381.1970.tb10363.x.

Antagonism of some smooth muscle actions of prostaglandins by polyphloretin phosphate

Antagonism of some smooth muscle actions of prostaglandins by polyphloretin phosphate

K E Eakins et al. Br J Pharmacol. 1970 Jul.

Abstract

1. The antagonism of the smooth muscle stimulating actions of PGF(2a) and PGE(2) by polyphloretin phosphate (PPP) was studied on several isolated smooth muscle preparations and on the blood pressure of the anaesthetized rabbit.2. PPP (2.5-20 mug/ml) reversibly inhibited contractions of the jird colon produced by PGE(2) or PGF(2a); PGF(2a) was more readily antagonized than PGE(2).3. PPP (2.5-30 mug/ml) reversibly antagonized contractions produced by PGE(2) and PGF(2a) on the isolated rabbit jejunum and uterus. In these preparations PPP antagonized PGE(2) as readily as PGF(2a).4. It is concluded that PPP is a selective antagonist to the prostaglandins on these tissues, for contractions produced by other agonists, such as acetylcholine, angiotensin, 5-hydroxytryptamine and bradykinin were not reduced by concentrations of PPP which markedly antagonized responses to the prostaglandins.5. Intravenous injections of PPP (25-200 mg/kg) resulted in a variable antagonism to the fall in blood pressure produced by intravenous injections of PGF(2a) in the anaesthetized rabbit; vasodepressor responses produced by PGE(2) and acetylcholine were not antagonized.6. The mechanism of this antagonism by PPP is not clear and must await further investigation.

PubMed Disclaimer

References

    1. Br J Pharmacol Chemother. 1968 May;33(1):162-70 - PubMed
    1. Br J Ophthalmol. 1961 Jul;45(7):482-9 - PubMed
    1. Acta Chir Scand. 1960 May 25;119:1-7 - PubMed
    1. Arch Int Pharmacodyn Ther. 1969 Jul;180(1):46-56 - PubMed
    1. Nature. 1969 Jul 12;223(5202):208-10 - PubMed

LinkOut - more resources